- AbCellera Biologics 🔍
- AbCellera to Report Third Quarter 2024 Financial Results on ...🔍
- ADMA Biologics Announces Second Quarter 2024 Financial Results ...🔍
- AbCellera to Report Second Quarter 2024 Financial Results on ...🔍
- AbCellera Biologics Reports Strong Q3 2024 Financial Results in ...🔍
- AbCellera Biologics Inc. 🔍
- Earnings call🔍
- abcl|20240630🔍
AbCellera to Report Second Quarter 2024 Financial Results on ...
AbCellera Biologics (ABCL) Q2 2024 Earnings Call Transcript
We expect research fee revenue to continue to trend lower as we increasingly focus on internal and co-development programs. Our research and ...
AbCellera to Report Third Quarter 2024 Financial Results on ...
VANCOUVER, British Columbia — AbCellera (Nasdaq: ABCL) will announce its third quarter 2024 financial results on Monday, November 4, 2024, ...
ADMA Biologics Announces Second Quarter 2024 Financial Results ...
Total revenues were $107.2 million for the quarter ended June 30, 2024, as compared to $60.1 million for the quarter ended June 30, 2023, an increase of $47.1 ...
AbCellera to Report Second Quarter 2024 Financial Results on ...
25/06/2024 - Abcellera Biologics Inc.: AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024.
AbCellera Biologics Reports Strong Q3 2024 Financial Results in ...
AbCellera Biologics, a biotechnology company based in Vancouver, has recently announced its strong financial performance for the third quarter ...
AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Misses Revenue ...
AbCellera Biologics (ABCL) delivered earnings and revenue surprises of 13.33% and 27.71%, respectively, for the quarter ended June 2024.
AbCellera to Report Second Quarter 2024 Financial Results on ...
VANCOUVER, British Columbia — AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings ...
Earnings call: AbCellera reports steady Q3 2024 revenue amidst ...
Despite a consistent revenue of $7 million compared to the same quarter last year, the company's R&D expenses have increased to $41 million, ...
Financial Statements. AbCellera Biologics Inc. Condensed Consolidated Balance Sheets. (All figures in U.S. dollars. Amounts ...
News of ABCELLERA BIOLOGICS INC(NASDAQ:ABCL) stock
ABCL earnings call for the period ending June 30, 2024. News Image. 3 months ago - AbCellera Biologics Inc. AbCellera Reports Q2 2024 Business Results.
AbCellera Biologics Inc. (ABCL) Stock Price, Quote & News
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $ABCL--AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024. 5 months ago - Business ...
Abcellera Biologics Inc. (ABCL) 8-K Earnings Release ... - Last10K
downstreams in Q3 2024 (up from 84 on September 30, 2023). AbCellera's partners have advanced a cumulative total of 14 molecules into the clinic ...
AbCellera Biologics Inc. filed SEC Form 8-K: Results of Operations ...
In connection with its earnings call on November 4, 2024, to discuss its results for the quarter ended September 30, 2024, the Company will ...
AbCellera Biologics Inc. (ABCL:US) | News & Upcoming Events
AbCellera Reports Q2 2024 Business Results. Business Wire AUG 6, 2024 4:05 PM EDT. AbCellera (Nasdaq: ABCL) today announced financial results for ...
AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024 https://investors.abcellera.com/news/news-releases/2024/AbCellera-to-Report ...
AbCellera Reports Q3 2024 Business Results - The Globe and Mail
Funds flow from operating activities from continuing operations totaled $640 in the quarter, versus funds used of $331 for Q3 2023 (see “Non- ...
ABCL - AbCellera Biologics Inc Stock Price and Quote - FINVIZ.com
AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024. (Business Wire). Jun-13-24 05:40AM · Down 57%, Is AbCellera Biologics a Buy on the ...
AbCellera Biologics (ABCL) Earnings Dates & Reports - TipRanks.com
AbCellera Biologics (ABCL) will release its next earnings report on Feb 24, 2025. In the last quarter AbCellera Biologics reported -$0.124 EPS in relation ...
Events & Presentations - AbCellera Biologics Inc. - Investor Relations
Archived Events ; Nov 04, 2024 05:00 PM ET. Q3 2024 Earnings Results and Business Update ; Sep 17, 2024 11:30 AM ET. Cantor Global Healthcare Conference ; Sep 05, ...
AbCellera Biologics Inc. - cloudfront.net
... financial and operational results for the quarter ended September 30, 2024. ... AbCellera Reports Q3 2024 Business Results. 11/04/2024.